Muutke küpsiste eelistusi

guide to establishing a national haemovigilance system [Pehme köide]

  • Formaat: Paperback / softback, 44 pages
  • Ilmumisaeg: 28-Jul-2017
  • Kirjastus: World Health Organization
  • ISBN-10: 924154984X
  • ISBN-13: 9789241549844
Teised raamatud teemal:
guide to establishing a national haemovigilance systemSuurem pilt
  • Formaat: Paperback / softback, 44 pages
  • Ilmumisaeg: 28-Jul-2017
  • Kirjastus: World Health Organization
  • ISBN-10: 924154984X
  • ISBN-13: 9789241549844
Teised raamatud teemal:
Püsilink: https://www.kriso.ee/db/9789241549844.html
Haemovigilance includes the monitoring, reporting, investigation, and analysis of adverse events related to the donation, processing, and transfusion of blood and taking actions to prevent their occurrence or recurrence. The document aims to support countries in establishing effective national systems for haemovigilance throughout the transfusion chain. It provides policy guidance on establishing a haemovigilance system as part of the national blood and health systems and includes technical information and guidance on the specific measures and actions necessary for implementing a haemovigilance system.

This document is intended for ministries of health; bodies responsible for policy-making on blood safety, such as national blood commissions or councils; regulatory agencies; public health institutions; blood transfusion services, blood centers, and plasma collection centers; hospitals, including hospital blood banks or health care facilities where transfusion takes place; blood donor organizations and other nongovernmental organizations involved in blood donor education and recruitment; patient groups; scientific and professional bodies; and developmental partners and international organizations.
Preface 1(1)
Acknowledgements 2(1)
1 Introduction
3(3)
1.1 Goal of haemovigilance
3(1)
1.2 Benefits of haemovigilance
3(2)
1.3 Characteristics of successful haemovigilance systems
5(1)
2 Organizational models for a national haemovigilance system
6(3)
3 Prerequisites for an effective national haemovigilance system
9(3)
3.1 Policy and legislative framework
9(1)
3.2 Leadership and governance
10(1)
3.3 Quality systems
10(1)
3.4 Organization and coordination
10(1)
3.5 Human and financial resources
10(1)
3.6 Traceability
11(1)
4 Planning a national haemovigilance system
12(2)
5 Organization and coordination of haemovigilance activities
14(4)
5.1 Haemovigilance in the donation and provision of blood and blood products
15(1)
5.2 Haemovigilance in clinical transfusion
15(1)
5.3 National haemovigilance activity
16(2)
6 National management and use of haemovigilance data
18(3)
6.1 Standard forms
18(1)
6.2 Analysis and feedback reporting
19(1)
6.3 Rapid alert systems
20(1)
7 Capacity and skill building in haemovigilance
21(2)
8 Monitoring, evaluation and outcomes
23(1)
9 International haemovigilance activity
24(4)
Glossary
25(1)
Annexes
26(2)
1 Standardized template form for the notification of a complication or an adverse reaction in a donor by the blood establishment
28(2)
2 Standardized template form for the notification of an adverse event in a blood establishment: part A, rapid notification
30(1)
3 Standardized template form for the notification of an adverse event in a blood establishment: part B, confirmation and finalization
31(1)
4 Standardized template form for the notification of an adverse reaction in a recipient: part A, rapid notification by the hospital
32(2)
5 Standardized template form for the notification of an adverse reaction in a recipient: part B, confirmation and finalization of the notification by the hospital
34(1)
6 Standardized template form for the notification of an adverse event in a hospital: part A, rapid notification
35(1)
7 Standardized template form for the notification of an adverse event in a hospital: part B, confirmation and finalization of a notification
36(1)
8 Standardized periodic reporting template on complications or adverse reactions observed in donors by blood establishments
37(2)
9 Standardized periodic reporting template on adverse events occurring in blood establishments
39(2)
10 Standardized annual reporting template on adverse reactions observed in recipients by hospitals (health care institutions)
41(2)
11 Standardized annual reporting template on adverse events occurring in hospitals (health care institutions)
43